LSTALisata Therapeutics, Inc.
NASDAQ · Materials · Large Cap · Mkt cap $1.31T · Vol 41.18M
$14.80
▼ -1.85% today
Fetching live price…
God's Eye forensics
Accounting quality and solvency screens. Anything that can't be computed from available filings data is left blank rather than estimated.
Piotroski F-Score
5/55
5 of 5 financial-health checks passed (4 checks need data this provider doesn't publish).
Altman Z-Score
Insufficient data—
Needs total assets, operating profit and debt — not published for this listing yet.
Beneish (earnings quality)
Insufficient data—
The full manipulation model needs two years of receivables, depreciation and accrual data, which isn't published for this listing.
Scores are free. The criteria-by-criteria breakdown — exactly which checks this company failed — is part of DeepScreen Pro.
Fundamental breakdown — raw ratios are free · fetching live data — showing modeled estimates for now
P/E Ratio (TTM)
Modeled9.5x
Cheap vs. earnings
Contextual insight — DeepScreen Pro
PEG Ratio
Modeled0.63
Undervalued vs. growth
Contextual insight — DeepScreen Pro
P/S Ratio
Modeled1.39x
Modest sales multiple
Contextual insight — DeepScreen Pro
P/B Ratio
Modeled2.40x
Reasonable
Contextual insight — DeepScreen Pro
EV/Revenue
Modeled1.96x
Low (value zone)
Contextual insight — DeepScreen Pro
EV/EBITDA
Modeled6.5x
Attractive
Contextual insight — DeepScreen Pro
ROE
Modeled25.3%
Excellent shareholder returns
Contextual insight — DeepScreen Pro
ROA
Modeled13.1%
Assets working hard
Contextual insight — DeepScreen Pro
ROCE
Modeled20.5%
High-quality compounder
Contextual insight — DeepScreen Pro
Debt / Equity
Modeled0.58x
Manageable
Contextual insight — DeepScreen Pro
LT Debt / Equity
Modeled0.36x
Moderate long-term leverage
Contextual insight — DeepScreen Pro
Payout Ratio
Modeled56%
Ideal balance — sustainable with room to reinvest
Contextual insight — DeepScreen Pro
Operating Leverage
Modeled2.08x
Good upside gearing
Contextual insight — DeepScreen Pro
Company financials
- EPS (TTM)
- $1.56
- Revenue (TTM)
- $942.0B
- Net margin
- 14.6%
- EBITDA margin
- 30.2%
- Earnings growth
- 15.1%
- Dividend yield
- 5.89%
- Payout ratio
- 56%
- Debt / equity
- 0.58x
Live data hasn't loaded yet — figures shown are DeepScreen's modeled estimates.
LSTA live news
LIVELoading live headlines…